MedTrace Logo

VividWhite Glaucoma Implant (VW-51) Pivotal Study

NCT06176170 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2025-11-18

No results posted yet for this study

Summary

The VividWhite Glaucoma Implant (VW-51) is a novel surgical implant designed to treat glaucoma. This study is a 12-month, 65-participant non-comparative multicentre study to assess the safety and effectiveness of the VW-51 implant.

Conditions

Interventions

DEVICE

VividWhite Glaucoma Implant (VW-51)

Subconjunctival surgical implantation of the VW-51 implant in the study eye.

Sponsors & Collaborators

  • VividWhite Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Michael Coote · Melbourne Eye Specialists

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-12
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06176170 on ClinicalTrials.gov